In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results